EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MRI-derived T stage predicts nodal positivity on PSMA PET/CT in high-risk primary prostate cancer

Michael Courtney, Robert Whiriskey, Ciaran Johnston, Niall Sheehy

Frontiers in Nuclear Medicine · 29.07.2026 · 6

DOI: 10.3389/fnume.2026.1854064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Nuclear Medicine, online erschienen am 29.07.2026. Verfasst von Michael Courtney und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, St. James's Hospital, Dublin, Ireland. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

We evaluated whether Magnetic Resonance Imaging (MRI)-Derived T Stage independently predicts nodal disease on Prostate-Specific Membrane Antigen (PSMA) PET/CT in patients with high-risk primary prostate cancer, and developed a predictive model for clinical decision support. Materials and methods MRI-derived T Stage, Prostate-Specific Antigen (PSA), Gleason score, age and PSMA node status were analysed using univariable and multivariable logistic regression in 152 men with high-risk primary prostate cancer who underwent pre-treatment multiparametric MRI and PSMA PET/CT. Model performance was assessed with area under the receiver operating characteristic (ROC) curve (AUC), calibration plots, and decision curve analysis. Subgroup analyses evaluated Gleason 3 + 4 and 4 + 3 disease separately.

Results

MRI T3b and T4 stages were independently and significantly associated with increased risk of PSMA-positive nodal disease ( p < 0.001 and p = 0.016, respectively). T3a disease was not significantly independently associated with PSMA-positive nodal disease ( p = 0.086). T3b remained an independent predictor even in Gleason 4 + 3 cases ( p = 0.026; odds ratio ≈ 23.57). The final model (AUC = 0.863) was well-calibrated and demonstrated clinical net benefit on decision curve analysis. In our cohort, patients with PSA < 20 ng/mL, MRI-derived T2 disease, and Gleason score < 8 (including both 3 + 4 and 4 + 3 patterns) demonstrated a 0% rate of PSMA-positive nodal disease.

Conclusion

MRI-derived T stage T3b disease is a strong independent predictor of PSMA-positive nodal disease. These findings support guideline-based staging criteria and support the integration of MRI-derived T Stage into PSMA PET/CT triage workflows.

Schlagwörter

Stichwörter der Autor:innen

MRIPSMA PET/CTnuclear medicineprostate cancerrisk stratification

Autor:innen und Institutionen

  • Department of Nuclear Medicine, St. James's Hospital, Dublin, Ireland.

Zitieren

APA

Courtney, M., Whiriskey, R., Johnston, C., & Sheehy, N. (2026). MRI-derived T stage predicts nodal positivity on PSMA PET/CT in high-risk primary prostate cancer. Frontiers in Nuclear Medicine, 6. https://doi.org/10.3389/fnume.2026.1854064

Vancouver

Courtney M, Whiriskey R, Johnston C, Sheehy N. MRI-derived T stage predicts nodal positivity on PSMA PET/CT in high-risk primary prostate cancer. Frontiers in Nuclear Medicine. 2026;6. doi:10.3389/fnume.2026.1854064

BibTeX
@article{Courtney2026,
  author = {Courtney, Michael and Whiriskey, Robert and Johnston, Ciaran and Sheehy, Niall},
  title = {MRI-derived T stage predicts nodal positivity on PSMA PET/CT in high-risk primary prostate cancer},
  journal = {Frontiers in Nuclear Medicine},
  year = {2026},
  volume = {6},
  doi = {10.3389/fnume.2026.1854064}
}
Kostenlos starten →